Hasil Pencarian  ::  Simpan CSV :: Kembali

"Penatalaksanaan dengan reradiasi pada pasien kanker serviks rekuren yang sebelumnya telah mendapatkan radiasi masih dianggap kontroversial, dan saat ini di Indonesia belum ada data mengenai bagaimana respon terapi dan efek sampingnya. Penelitian ini bertujuan untuk menilai respon terapi dan efek samping yang terjadi pada reradiasi, dan menilai pengaruh interval waktu antara radiasi pertama dengan terjadinya rekurensi terhadap respon terapi dan efek samping, serta pengaruh ukuran tumor terhadap respon terapi reradiasi.Metodologi: Studi retrospektif kohort tanpa pembanding, dilakukan di Departemen Radioterapi RSCM pada pasien kanker serviks rekuren yang menjalani reradiasi dan memenuhi kriteria inklusi sejak Januari 2007 sampai dengan Desember 2012. Data berasal dari rekam medis pasien dan follow up melalui telepon.Hasil: Sebanyak 22 pasien masuk dalam penelitian ini. Sembilan pasien (40,9%) mengalami respon komplit, 10 pasien (45,5%) respon parsial, 1 pasien (4,5%) respon stabil, dan 2 pasien (9,1%) tumor progresif. Secara keseluruhan dijumpai 15 pasien (68,2%) yang mengalami efek samping dari tidak ada sampai ringan (RTOG grade 0-2) dan 7 pasien (31,8%) yang mengalami efek samping berat (RTOG garde 3-4). Efek samping akut gastrointestinal berat dijumpai pada 4 pasien (18,1%), efek samping lanjut gastrointestinal berat pada 6 pasien (27,3%) dan 2 pasien (9,1%) dengan efek samping genitourinarius berat, dan tidak dijumpai pasien dengan efek samping lanjut genitourinarius berat.Tidak terdapat perbedaan yang bermakna padarespon terapi dan efek samping antara pasien dengan interval waktu rekurensi < 12 bulan vs ≥ 12 bulan (p=0,544, dan p=1.000). Tidak terdapat perbedaan yang bermakna pada respon terapi antara pasien dengan ukuran ≤4 cm vs >4 cm.(p=1.000).Kesimpulan: Reradiasi dapat dipertimbangkan sebagai modalitas terapidalam penatalaksanaan kanker serviks rekuren karena didapatkan respon terapi yang baik dan mayoritas mengalami efek samping dari tidak ada sampai ringan (RTOG grade 0-2). Pada penelitian ini tidak ditemukan hubungan antara perbedaan interval waktu rekurensi <12 bulan vs ≥12 bulan terhadap respon terapi dan efek samping. Tidak ditemukan pula hubungan antara perbedaan ukuran tumor ≤4 cm vs >4 cm terhadap respon tumor.

---

Management by reirradiation for the recurrent cervical cancer patient after having undergone radiation treatment is still controversial, and currently, in Indonesia, there are no data about its tumour response and side effects. This study aims to assess the tumour response and side effects in reirradiation, to assess the effect of time gap between first radiation treatment and recurrence on tumour response and side effects, and to assess the effect of tumour size on tumour response.

Methods: A cohort retrospective study with no comparison was done at Radiotherapy Department Cipto Mangunkusumo National General Hospital, Jakarta in recurrent cervical cancer patients undergoing reirradiation according to the inclusion criteria between January 2007 and December 2012. The data were collected from patients’ medical record and the patients were followed up with phone calls.

Result: There were 22 patients in this study. Nine patients (40,9%) had complete response, 10 patients (45,5%) had partial response, 1 patient (4,5%) had stable response, and 2 patients (9,1%) had tumour progression. In general, 15 patients (68,2%) had no until light side effects (grade 0-2 RTOG), and 7 patients had severe side effects (grade 3-4 RTOG). Four patients (18,1%) had severe gastrointestinalacute side effects, 6 patients (27,3%) had severe gastrointestinal late side effects, 2 patients (9,1%) had severe genitourinarius side effects, and there were no patients had severe genitourinarius late side effects. There was no significant difference between patients with time gap between first radiation treatment and recurrence<12 montsh vs ≥ 12 months (p=0.5444, and p=1.000). There is no significant difference between patients with tumour size ≤ 4cm vs > 4cm (p=1.000).

Conclusion: Reirradiation can be considered as a modality in recurrent cervical cancer management because good tumour response can be achieved and majority of the patients had no until light side effect (grade 0-2 RTOG). This study found there was no correlation between difference time gap between first radiation treatment and recurrence <12 montsh vs ≥ 12 months, and there wss no correlation between difference tumour size ≤ 4cm vs > 4cm."

"Tujuan: Membandingkan distribusi dosis respon akhir RE dan efek samping akut RE teknik konvensional dan teknik konformal pada kasus kanker serviks lokal lanjut Metode Dilakukan studi kohort retrospektif terhadap pasien kanker serviks II B dan III B yang mendapat RE pra brakiterapi di Dept Radioterapi RSCM. Hasil: Didapat 51 pasien menjalani RE teknik konvensional 25 dengan Cobalt 60 26 dengan Linac dan 29 pasien menjalani teknik konformal Sesuai ketentuan ICRU 50 dan 62 prescribed dose dan cakupan volume target teknik konvensional Cobalt lebih kecil p 0 001 dan 1 kasus dari 25 pasien mendapatkan PTV 95 Prescribed dose dan cakupan volume target teknik konvensional Linac lebih besar p 0 001 dibanding teknik konformal Rerata conformity index teknik konvensional sebesar 2 dan teknik konformal 1 02 p 0 001 Dosis dan volume pada buli rektosigmoid dan bowel teknik konvensional lebih besar p 0 001 Respon komplit akhir RE teknik konvensional adalah 42 dan teknik konformal adalah 58 p 0 001 Faktor independen respon akhir RE yaitu stadium FIGO dini dan ukuran tumor sebelum RE kecil le 4cm Pada semua kasus tidak didapatkan efek samping akut lokal yang berat RTOG grade 3 4 Proporsi efek samping ringan RTOG grade 1 2 pada gastrointestinal vesikourinaria dan kulit lebih banyak pada teknik konvensional secara berurutan 72 Vs 28 p 0 002 78 Vs 22 p 0 003 dan 78 Vs 22 p 0 01. Kesimpulan: RE teknik konformal lebih unggul dibanding teknik konvensional dalam distribusi prescribed dose dan cakupan volume target atau organ kritis yang berdampak pada respon tumor akhir RE dan efek samping.

---

Purpose: To compare the dose distribution acute tumor response and acute side effects between conventional and conformal techniques EBRT in locally advanced uterine cervical cancerMethods and materials Retrospective cohort study was done in stage II B and III B uterine cervical cancer underwent EBRT before brachytherapy in Dept Radioterapi RSUPN Cipto Mangunkusumo.

Results: Fifety one patients underwent conventional technique EBRT and 29 patients of conformal technique EBRT The average of target prescribed dose and volume coverage of 2 techniques EBRTwas in accordance with criteria of ICRU 50 and 62 smaller p 0 001 only 1 case of Cobalt conventional technique EBRT showed PTV 95 Conformity index of conventional technique EBRT was 2 and conformal technique EBRT was 1 02 p 0 001 Dose and volume of vesicourinary rectosigmoid and distal large bowel of conventional technique EBRT was greater p 0 001 Complete response of conventional technique was 42 and conformal technique was 58 p 0 001 Independent factors were early FIGO stage and tumor size before EBRT le 4cm There were no severe acute side effects RTOG grade 3 4 in both groups Acute side effects RTOG grade 1 2 of conventional techniques was more than conformal gastrointestinal vesikourinaria and skin respectively 72 vs 28 p 0 002 78 vs 22 p 0 003 and 78 vs 22 p 0 01.

Conclusion: Conformal technique EBRT was superior to conventional technique EBRT in prescribed dose distribution target volume coverage and organ at risk dose that impact on acute tumor response and side effects "

"Latar Belakang: Kanker serviks masih menjadi kanker tersering kedua di Indonesia dengan insiden 2638 kasus pada tahun 2008. Sejak tahun 1999, National Cancer Institute merekomendasikan penatalaksanaan kanker serviks dengan menggunakan kemoradiasi. Namun selama ini tatalaksana kanker serviks lebih banyak mengacu untuk klasifikasi histopatologi karsinoma sel skuamosa, sementara angka kanker serviks dengan tipe sel adenokarsinoma meningkat dan menurut beberapa penelitian memiliki prognosis yang lebih buruk. Tujuan: Penelitian ini memiliki tujuan mengetahui perbandingan keberhasilan terapi dengan kemoradiasi dibandingkan dengan radiasi saja serta untuk mengetahui adanya perbedaan respon terapi pada kanker serviks dengan klasifikasi histopatologi karsinoma sel skuamosa dan adenokarsinoma. Metode: yang digunakan adalah secara cross sectional dimana sampel diambil dari pasien kanker serviks IIB ndash; IIIB pada tahun 2011 ndash; 2013 di RSCM yang menjalani terapi radiasi atau kemoradiasi. Hasil: Dari 163 sampel yang dipelajari, sebanyak 107 pasien adalah pasien dengan karsinoma sel skuamosa dan 56 pasien dengan adenokarsinoma. Menurut klasifikasi histopatologi, karsinoma sel skuamosa didapatkan memiliki angka respon lengkap yang tidak berbeda secara signifikan, yaitu 82,2 dibandingkan dengan adenokarsinoma 78,6 p = 0,721 Sebanyak 67,5 pasien mendapatkan terapi radiasi dan 32,5 mendapatkan terapi kemoradiasi dengan agen kemoterapi berbasis platinum, terapi dengan kemoradiasi didapatkan memiliki respon terapi yang lebih baik yaitu dengan angka respon lengkap sebanyak 98,1 dibandingkan dengan radiasi 72,7 p = 0,001 . Pada kelompok pasien yang dilakukan radiasi, pasien dengan karsinoma sel skuamosa tidak memiliki respon yang berbeda dengan kemoradiasi, yaitu respon komplit 76,9 dibandingkan dengan 62,5 p= 0,191 . Begitu juga dengan kelompok kemoradiasi, tidak ada perbedaan respon terapi antara pasien karsinoma sel skuamosa 96,6 dengan adenokarsinoma 100. Kesimpulan: Dari penelitian ini didapatkan tidak ada perbedaan respon terapi pada tipe sel karsinoma sel skuamosa dan adenokarsinoma. Pada masing-masing kelompok radiasi dan kemoradiasi, karsinoma sel skuamosa dan adenokarsinoma tidak terdapat perbedaan. Pasien yang diterapi dengan kemoradiasi memiliki respon terapi yang lebih baik dibandingkan radiasi saja.

---

Background: Cervical cancer is the second most frequent cancer in Indonesia with incident of 2638 cases in 2008. Since 1999, National Cancer Institute in the United States recommend to give concurrent chemoradiation for advanced stage cervical cancer. Until now the therapy recommention mostly addressed for squamous cell carcinoma, meanwhile the incidence of adenocarcinoma arise with also worse prognosis.

Objective: To know the correlation between histopathological type squamous cell carcinoma and adenocarcinoma with the teurapeutic response and to compare the response of treatment using radiation only and chemoradiation.

Method: This study was using cross sectional method, sampel was taken by secondary data using medical report of patient with cervical cancer staged IIB IIIB year 2011 ndash 2013 at RSCM who underwent radiation and chemoradiation.

Result: From 163 subjects, 107 was patient with squamous cell carcinoma and 56 patients with adenocarcinoma. According to histopathological type, squamous cell carcinoma and adenocarcinoma had insignificant difference in theurapetical response, which is 82,2, compared to 78,6 p 0,721. There were 67,5 patients got radiation only and 32,5 got concurrent chemoradiation therapy using platinum based agent. Among patient who were treated with chemoradiation, 98,1 patients achieved complete respons and for patient with radiation only 72,7 achieved complete respons 72,7 p 0,001. Patients who were treated with radiation only, when compared to its pathological type, the complete respons were not different 76,9 in squamous cell carcinoma, compared to 62,5 in adenocarcinoma p 0,191. And so as patient with chemoradiation, there were no difference in theurapetical respons in squamous cell carcinoma 96,6 compared with 100 in adenocarcinoma.

Conclusion: There was no difference in theurapetical respons in patient with squamous cell carcinoma compared to adenocarcinoma. Chemoradiation appeared to have better theurapetic respon compared to radiation only therapy. In each theurapetic modality group the respon therapy for squamous cell carcinoma and adenocarcinoma had no difference in theurapetical response."

"Tujuan. Penelitian ini bertujuan untuk mengetahui profil Treg (ditunjukkan oleh Foxp3), CD4, dan CD8 pada kanker serviks stadium lanjut lokal dan dampaknya terhadap progresivitas tumor dan respons radiasi. Metode. Setelah disetujui oleh komite penelitian, kami mengumpulkan data pasien kanker serviks stadium lanjut lokal yang menjalani radioterapi, di RSCM, Jakarta, pada Januari 2018 – Desember 2020. Subjek penelitian harus memiliki pencitraan pra dan paska radiasi dan spesimen blok parafin untuk memenuhi syarat dalam penelitian ini. Profil Foxp, CD4, dan CD8, akan dianalisis dengan imunohistokimia dengan penghitungan jumlah sel. Respons radiasi akan dianalisa dengan kriteria RECIST 1.1. Semua informasi klinis pasien yang diperlukan akan dikumpulkan dari rekam medis elektronik. Hasil. Kami menemukan bahwa sebagian besar pasien memiliki karsinoma sel skuamosa (93%), stadium IIIC (48%), dan menjalani radiasi saja (72%). Evaluasi RECIST menunjukkan 62% pasien memiliki respons lengkap, 28% respons parsial, dan 10% respons buruk (penyakit stabil dan progresif). Kami dapatkan median jumlah sel CD4 =29 (7 – 154), CD8 = 30 (6 – 227), dan Foxp3 = 36 (2 – 156). Tidak ada hubungan bermakna antara jumlah sel limfosit CD4, CD8, dan Foxp3 dengan volume tumor, dengan p = 0.858; p = 0.975, dan p = 0.723 masing masing. Tidak ada hubungan bermakna dengan dimensi terbesar tumor dengan p = 0.481, p = 0.480, dan p = 0.792 masing masing. Tidak ada pula hubungan bermakna antara jumlah sel limfosit CD4, CD8, dan Foxp3 dengan respons radiasi dengan p = 0.964, p = 0.296, dan p = 0.787 masing masing. Namun kami mendapatkan korelasi positif yang kuat dan bermakna pada jumlah sel tumor pada stroma, CD 4 - CD8 (r = 0.580, p=0.001); CD4 - Foxp3 (r = 0.699, p < 0.001), dan CD8 - Foxp3 (r = 0.652, p < 0.001). Kesimpulan. Sebagian besar pasien kanker stadium lanjut lokal yang menjalani radiasi memiliki respons lengkap. Tidak didapatkan hubungan bermakna antara jumlah sel limfosit CD4, CD8, dan Foxp3 dengan volume tumor, dimensi terbesar tumor, dan respons radiasi. Terdapat korelasi yang kuat dan signifikan antar sel imun (CD4-CD8, CD4-Foxp3, dan CD8-Foxp3) pada lingkungan stroma.

---

Aims: This study aims to determine profile of Treg (shown by Foxp3), CD4, and CD8 in locally advanced cervical cancer and the impact to tumor progressivity and radiation response. Method. After been approved by the institution research committee, we collect data of locally advanced of cervical cancer patients who underwent radiotherapy, at RSCM, Jakarta, in January 2018 – December 2020. Studies subjects must have pre and post irradiation imaging and paraffin block specimen to be eligible in this study. Profile of Foxp, CD4, and CD8, will be analyzed by immunohistochemistry, by counting the number of cells, and radiation response will be analyzed by RECIST 1.1 criteria. All necessary patient’s clinical information will be collected from electronic medical record. Result. We found that most of the patients had squamous cell carcinoma (93%), stage IIIC (48%), and underwent radiation alone (72%). RECIST evaluation showed 62% of patients had a complete response, 28% a partial response, and 10% had a poor response (stable and progressive disease). We found median CD4 cell counts = 29 (7 – 154), CD8 = 30 (6 – 227), and Foxp3 = 36 (2 – 156). There was no significant relationship between the number of CD4, CD8, and Foxp3 lymphocytes with tumor volume, with p = 0.858; p = 0.975, and p = 0.723 respectively. There was no significant relationship with the dimensions of the largest tumor with p = 0.481, p = 0.480, and p = 0.792, respectively. There was no significant relationship between the number of CD4, CD8, and Foxp3 lymphocytes with radiation response with p = 0.964, p = 0.296, and p = 0.787, respectively. However, we found a strong and significant positive correlation in the number of tumor cells in the stroma, CD4 - CD8 (r = 0.580, p = 0.001); CD4 - Foxp3 (r = 0.699, p < 0.001), and CD8 - Foxp3 (r = 0.652, p < 0.001). Conclusion. Most locally advanced cancer patients who undergo radiation have a complete response. There are no significant relationships between the number of CD4, CD8, and Foxp3 lymphocytes with tumor volume, largest tumor dimensions, and radiation response. There is a strong and significant correlation between immune cells (CD4-CD8, CD4-Foxp3, and CD8-Foxp3) in the stromal environment."

"Latar Belakang: Kanker serviks stadium awal dapat ditatalaksana dengan baik, namun pada stadium lanjut lokal memiliki prognosis yang buruk. Terapi standar yang tersedia masih kurang optimal dan memiliki efek samping yang mengganggu. Pada keadaan tertentu tumor dapat mengalami metastases atau progresif, salah satunya karena adanya ikatan PD-L1 dengan sel limfosit T sehingga kanker serviks terhindar dari respon imun. Pemberian anti PD-L1 menjadi bagian yang penting dalam pengobatan imunoterapi kanker. Di Indonesia belum tersedia data empirik profil karakteristik yang berkaitan dengan ekspresi PD-L1 serta respon tumor terhadap radiasi pada kanker serviks.Metode: Penelitian ini memeriksa ekspresi PD-L1 intratumoral pada jaringan biopsi karsinoma sel skuamosa serviks pre dan paska radiasi eksterna dengan menggunakan metode ELISA dan IHK, pemeriksaan IHK menggunakan antibodi clone 28-8 dari Abcam. Pemeriksaan CT scan evaluasi sebelum radiasi dan 2 bulan setelah radiasi dipakai sebagai alat untuk menilai respon terapi radiasi.Hasil: Dari 31 pasien yang ikut serta, terdapat 29 pasien yang telah dilakukan pemeriksaan ekspresi PD-L1 sebelum dan sesudah radiasi, selanjutnya hanya 22 pasien yang telah menjalani CT scan evaluasi. Ekspresi PD-L1 ELISA paska radiasi eksterna berbeda bermakna pada tumor berukuran ≥5cm (p=0,015) dan ekspresi PD-L1 IHK berbeda bermakna pada sel tumor berkeratin (p=0,023), pada pasien dengan grade IHK yang difus (+3) resiko relatif untuk respon komplit 0,5 kali dibandingkan dengan grade IHK yang  tidak difus.Uji korelasi perbedaan selisih ekspresi (delta) dan rasio PD-L1 ELISA menunjukkan tidak ada korelasi (R2 = 0,217) dan (R2 = 0,194) terhadap respons, begitu juga hasil pada hasil pemeriksaan ekspresi PD-L1 IHK tidak ada perbedaan bermakna pada kategori kenaikan, tetap dan penurunan, tetapi ketika kategori dirubah menjadi penurunan dan tidak ada penurunan didapatkan nilai p yang lebih baik (p=0,161 vs p=.0,613)Kesimpulan: Tidak terdapat perbedaan bermakna antara ekspresi PD-L1 pre dan paska radiasi terhadap respon, akan tetapi terdapat tren penurunan kadar PD-L1 IHK berkaitan dengan respon terapi.

---

Background: Early-stage cervical cancer can be managed properly, but at a locally advanced stage it has a poor prognosis. The standard therapy available is still suboptimal and has disturbing side effects. In certain circumstances, tumors can undergo metastases or progressives, one of which is due to the binding of PD-L1 with T lymphocyte cells so that cervical cancer is protected from the immune response. In Indonesia, there is no available empirical data on the characteristic profiles related to PD-L1 expression and tumor response to radiation in cervical cancer.

Method: This study examined intratumoral PD-L1 expression in biopsy tissue of squamous cell carcinoma of cervical cells pre and post external radiation using ELISA and IHC methods, IHC examination using antibody clone 28-8 from Abcam. CT scan evaluation before radiation and 2 months after radiation are used as a tool to assess the response of radiation therapy.

Results: Of the 31 patients who participated, there were 29 patients who had examined the expression of PD-L1 before and after radiation, then only 22 patients who had undergone a CT scan evaluation. Expression of PD-L1 ELISA after external radiation was significantly different in tumors of ≥5cm (p=0.015) and expression of PD-L1 IHC was significantly different in keratinous tumor cells (p = 0.023), in patients with diffuse IHC grade (+3) relative risk to complete response of 0.5 times compared to the grade of IHC which is not diffuse. Correlation test difference in expression difference (delta) and PD-L1 ELISA ratio showed no correlation (R2 =0.217) and (R2=0,194) to the response, as well as results on the examination results of PD-L1 IHC expression there was no significant difference in the increased category, constant and decrease, but when the category is changed to decrease and there is no decrease, a better p-value is obtained (p=0.161 vs p=0.613)

Conclusion: There was no significant difference between the expression of PD-L1 pre and post-radiation to the response, but there was a trend of decreasing PD-L1 IHC levels concerning therapeutic response."

"Latar Belakang : Kanker serviks stadium awal dapat ditatalaksana dengan baik, namun pada stadium lanjut lokal memiliki prognosis yang buruk. Terapi standar yang tersedia masih kurang optimal dan memiliki efek samping yang mengganggu. Pada keadaan tertentu tumor dapat mengalami metastases atau progresif, salah satunya karena adanya ikatan PD-L1 dengan sel limfosit T sehingga kanker serviks terhindar dari respon imun. Pemberian anti PD-L1 menjadi bagian yang penting dalam pengobatan imunoterapi kanker. Di Indonesia belum tersedia data empirik profil karakteristik yang berkaitan dengan ekspresi PD-L1 serta respon tumor terhadap radiasi pada kanker serviks. Metode: Penelitian ini memeriksa ekspresi PD-L1 intratumoral pada jaringan biopsi karsinoma sel skuamosa serviks pre dan paska radiasi eksterna dengan menggunakan metode ELISA dan IHK, pemeriksaan IHK menggunakan antibodi clone 28-8 dari Abcam. Pemeriksaan CT scan evaluasi sebelum radiasi dan 2 bulan setelah radiasi dipakai sebagai alat untuk menilai respon terapi radiasi. Hasil : Dari 31 pasien yang ikut serta, terdapat 29 pasien yang telah dilakukan pemeriksaan ekspresi PD-L1 sebelum dan sesudah radiasi, selanjutnya hanya 22 pasien yang telah menjalani CT scan evaluasi. Ekspresi PD-L1 ELISA paska radiasi eksterna berbeda bermakna pada tumor berukuran ≥5cm (p=0,015) dan ekspresi PD-L1 IHK berbeda bermakna pada sel tumor berkeratin (p=0,023), pada pasien dengan grade IHK yang difus (+3) resiko relatif untuk respon komplit 0,5 kali dibandingkan dengan grade IHK yang  tidak difus. Uji korelasi perbedaan selisih ekspresi (delta) dan rasio PD-L1 ELISA menunjukkan tidak ada korelasi (R2= 0,217) dan (R2= 0,194) terhadap respons, begitu juga hasil pada hasil pemeriksaan ekspresi PD-L1 IHK tidak ada perbedaan bermakna pada kategori kenaikan, tetap dan penurunan, tetapi ketika kategori dirubah menjadi penurunan dan tidak ada penurunan didapatkan nilai p yang lebih baik (p=0,161 vs p=.0,613).Kesimpulan : Tidak terdapat perbedaan bermakna antara ekspresi PD-L1 pre dan paska radiasi terhadap respon, akan tetapi terdapat tren penurunan kadar PD-L1 IHK berkaitan dengan respon terapi.

---

Correlation of Intratumoral PD-L1 Expression Before and After External Radiation to The Radiation Response in Locally Advanced Cervical Cancer.

Background: Early-stage cervical cancer can be managed properly, but at a locally advanced stage it has a poor prognosis. The standard therapy available is still suboptimal and has disturbing side effects. In certain circumstances, tumors can undergo metastases or progressives, one of which is due to the binding of PD-L1 with T lymphocyte cells so that cervical cancer is protected from the immune response. In Indonesia, there is no available empirical data on the characteristic profiles related to PD-L1 expression and tumor response to radiation in cervical cancer.

Method: This study examined intratumoral PD-L1 expression in biopsy tissue of squamous cell carcinoma of cervical cells pre and post external radiation using ELISA and IHC methods, IHC examination using antibody clone 28-8 from Abcam. CT scan evaluation before radiation and 2 months after radiation are used as a tool to assess the response of radiation therapy.

Results: Of the 31 patients who participated, there were 29 patients who had examined the expression of PD-L1 before and after radiation, then only 22 patients who had undergone a CT scan evaluation. Expression of PD-L1 ELISA after external radiation was significantly different in tumors of ≥5cm (p=0.015) and expression of PD-L1 IHC was significantly different in keratinous tumor cells (p = 0.023), in patients with diffuse IHC grade (+3) relative risk to complete response of 0.5 times compared to the grade of IHC which is not diffuse. Correlation test difference in expression difference (delta) and PD-L1 ELISA ratio showed no correlation (R2=0.217) and (R2=0,194) to the response, as well as results on the examination results of PD-L1 IHC expression there was no significant difference in the increased category, constant and decrease, but when the category is changed to decrease and there is no decrease, a better p-value is obtained (p=0.161 vs p=0.613).

Conclusion: There was no significant difference between the expression of PD-L1 pre and post-radiation to the response, but there was a trend of decreasing PD-L1 IHC levels concerning therapeutic response."

"[ABSTRAKLatar balakang. Sekitar 75% kanker leher rahim datang ke rumah sakit dalam stadium lanjut. Terapi utama kanker serviks stadium lanjut adalah radioterapi. Kombinasi terapi radiasi dengan kemoterapi ternyata tidak menghasilkan respons terapi yang lebih baik, tetapi bahkan menimbulkan efek samping yang lebih berat dibandingkan terapi radiasi saja. Perubahan pola makan saat ini, diduga berpengaruh pada respons terapi. Rasio asupan Polyunsaturated Fatty Acids (PUFA) n-6 : n-3 sekitar 1-2 : 1 dapat melawan pertumbuhan kanker. Beberapa publikasi melaporkan bahwa PUFA n-3 (AL n-3) mempunyai efek pro-apoptosis, anti-inflamasi, anti-proliferatif dan anti-angiogenik. Penelitian ini bertujuan untuk mengetahui apakah suplementasi nutrisi tinggi PUFA bersamaan dengan terapi radiasi dapat meningkatkan respons tumor pada kanker serviks stadium lanjut. Metode. Penelitian ini merupakan Randomized Clinical Trial, double blind pada pasien kanker serviks stadium lanjut, jenis karsinoma sel skuama yang hanya mendapat terapi radiasi di Departemen Radioterapi, Rumah Sakit Cipto Mangunkusumo (RSCM), Jakarta. Subjek penelitian diambil secara konsekutif, melalui randomisasi dibagi dua kelompok, yaitu kelompok perlakuan dan kontrol. Selama radiasi subjek penelitian mendapat suplementasi nutrisi mengandung isokalori dan isoprotein dengan rasio AL n-6 : n-3 = 1,27 : 1 dan kontrol. Selama perlakuan dilakukan evaluasi setiap lima kali radiasi, meliputi BB dan efek samping radiasi akut. Parameter yang dinilai adalah respons klinis, respons histopatologis serta perubahan kadar PGE2 dan VEGF serum.Hasil. Sebanyak 31 subjek dari 45 subjek dapat menyelesaikan penelitian. Sebelum perlakuan, status sosio-demografi, pola asupan AL n-6 dan n-3, status gizi dan klinis tidak didapatkan perbedaan bermakna. Setelah perlakuan, didapatkan penurunan kadar PGE2 serum pada kelompok perlakuan, sedangkan kelompok kontrol mengalami kenaikan (p = 0,127). Penurunan kadar VEGF kelompok perlakuan lebih besar dibanding kontrol (p = 0,626). Respons klinis dan respons histopatologis kelompok perlakuan lebih baik dibanding kontrol, dengan kemaknaan masing-masing p = 0,172 dan p = 0,169. Secara statistik belum didapatkan perbedaan yang bermakna pada penurunan kadar PGE2 dan VEGF serum, respons klinis dan respons histopatologis, tetapi didapat kemaknaan klinis yang nyata pada kelompok perlakuan dibanding kontrol. Analisis statistik gabungan dari respons klinis, respons histopatologis, kadar PGE2 dan VEGF serum didapatkan respons tumor total yang bermakna (p = 0,048).Kesimpulan. Suplementasi nutrisi tinggi PUFA dengan rasio asam lemak n-6 : n- 3 = 1,27 : 1 pada kanker serviks stadium lanjut bersama terapi radiasi memberikan respons tumor total yang lebih baik.;

---

ABSTRACTBackground . Approximately 75% of uterine cervical cancer came to the hospital in an advanced stage. Primary therapy of advanced cervical cancer is radiotherapy. The combination of radiotherapy with chemotherapy did not give better outcomes, but even cause more severe side effects than radiotherapy. Changes in dietary intake at this time, are supposed to influence the response to therapy. The ratio of n-6 to n-3 polyunsaturated fatty acids (PUFA) about 1-2: 1 can fight cancer growth. Several publications stated that n-3 PUFA has pro- apoptotic effect, anti-inflammatory, anti-proliferative and anti-angiogenic. This study aimed to examine whether radiotherapy combined with daily nutritional supplements enriched PUFA enhance tumor response in advanced cervical cancer.Method. This study was a double-blind Randomized Clinical Trial (RCT) in patients with advanced squamous cell cervical cancer, received radiation only as control group, and those who received nutritional supplementation containing isocaloric and isoprotein with ratio of n-6 : n-3 PUFA = 1.27: 1 as treatment group. This study was performed in the Department of Radiotherapy Dr. Cipto Mangunkusumo General Hospital (RSUPNCM), Jakarta. Evaluation was done every five times radiation, including Karnofsky Perfomance Scale, body weight and side effects of acute radiation. Parameters assessed were clinical and hematological response, histopathological response and changes in the levels of PGE2 and VEGF serum,Results. A total of 31 subjects from 45 subjects participated the study completely. Prior to treatment, socio-demographic status, patterns of n-6 and n-3 PUFA, clinical and nutritional status were analyzed, no significant differences were noted. After treatment, a decrease in serum PGE2 levels in the treatment group was found, while in the control group increased (P = 0.127). VEGF in the treatment group declined higher than controls (P = 0.626). Treatment group showed significant better clinical response and histopathological responses compared to the control group (p = 0.172 and p = 0.169). No significant differences were found in the reduction of PGE2 and VEGF serum levels, clinical response and histopathological response, although from clinical standpoint there is a better significant response in the treatment group than the control. The combined statistical analysis of clinical response, histopathological response, PGE2 and VEGF serum levels obtained total tumor response (P = 0.048). Conclusion. Nutritional supplementation enriched PUFA (ratio of n-6: n-3 PUFA = 1.27 : 1) in advanced cervical cancer receiving radiotherapy gives better total tumor response.;Background . Approximately 75% of uterine cervical cancer came to the hospital in an advanced stage. Primary therapy of advanced cervical cancer is radiotherapy. The combination of radiotherapy with chemotherapy did not give better outcomes, but even cause more severe side effects than radiotherapy. Changes in dietary intake at this time, are supposed to influence the response to therapy. The ratio of n-6 to n-3 polyunsaturated fatty acids (PUFA) about 1-2: 1 can fight cancer growth. Several publications stated that n-3 PUFA has pro- apoptotic effect, anti-inflammatory, anti-proliferative and anti-angiogenic. This study aimed to examine whether radiotherapy combined with daily nutritional supplements enriched PUFA enhance tumor response in advanced cervical cancer.Method. This study was a double-blind Randomized Clinical Trial (RCT) in patients with advanced squamous cell cervical cancer, received radiation only as control group, and those who received nutritional supplementation containing isocaloric and isoprotein with ratio of n-6 : n-3 PUFA = 1.27: 1 as treatment group. This study was performed in the Department of Radiotherapy Dr. Cipto Mangunkusumo General Hospital (RSUPNCM), Jakarta. Evaluation was done every five times radiation, including Karnofsky Perfomance Scale, body weight and side effects of acute radiation. Parameters assessed were clinical and hematological response, histopathological response and changes in the levels of PGE2 and VEGF serum,Results. A total of 31 subjects from 45 subjects participated the study completely. Prior to treatment, socio-demographic status, patterns of n-6 and n-3 PUFA, clinical and nutritional status were analyzed, no significant differences were noted. After treatment, a decrease in serum PGE2 levels in the treatment group was found, while in the control group increased (P = 0.127). VEGF in the treatment group declined higher than controls (P = 0.626). Treatment group showed significant better clinical response and histopathological responses compared to the control group (p = 0.172 and p = 0.169). No significant differences were found in the reduction of PGE2 and VEGF serum levels, clinical response and histopathological response, although from clinical standpoint there is a better significant response in the treatment group than the control. The combined statistical analysis of clinical response, histopathological response, PGE2 and VEGF serum levels obtained total tumor response (P = 0.048). Conclusion. Nutritional supplementation enriched PUFA (ratio of n-6: n-3 PUFA = 1.27 : 1) in advanced cervical cancer receiving radiotherapy gives better total tumor response., Background . Approximately 75% of uterine cervical cancer came to the hospital in an advanced stage. Primary therapy of advanced cervical cancer is radiotherapy. The combination of radiotherapy with chemotherapy did not give better outcomes, but even cause more severe side effects than radiotherapy. Changes in dietary intake at this time, are supposed to influence the response to therapy. The ratio of n-6 to n-3 polyunsaturated fatty acids (PUFA) about 1-2: 1 can fight cancer growth. Several publications stated that n-3 PUFA has pro- apoptotic effect, anti-inflammatory, anti-proliferative and anti-angiogenic. This study aimed to examine whether radiotherapy combined with daily nutritional supplements enriched PUFA enhance tumor response in advanced cervical cancer.Method. This study was a double-blind Randomized Clinical Trial (RCT) in patients with advanced squamous cell cervical cancer, received radiation only as control group, and those who received nutritional supplementation containing isocaloric and isoprotein with ratio of n-6 : n-3 PUFA = 1.27: 1 as treatment group. This study was performed in the Department of Radiotherapy Dr. Cipto Mangunkusumo General Hospital (RSUPNCM), Jakarta. Evaluation was done every five times radiation, including Karnofsky Perfomance Scale, body weight and side effects of acute radiation. Parameters assessed were clinical and hematological response, histopathological response and changes in the levels of PGE2 and VEGF serum,Results. A total of 31 subjects from 45 subjects participated the study completely. Prior to treatment, socio-demographic status, patterns of n-6 and n-3 PUFA, clinical and nutritional status were analyzed, no significant differences were noted. After treatment, a decrease in serum PGE2 levels in the treatment group was found, while in the control group increased (P = 0.127). VEGF in the treatment group declined higher than controls (P = 0.626). Treatment group showed significant better clinical response and histopathological responses compared to the control group (p = 0.172 and p = 0.169). No significant differences were found in the reduction of PGE2 and VEGF serum levels, clinical response and histopathological response, although from clinical standpoint there is a better significant response in the treatment group than the control. The combined statistical analysis of clinical response, histopathological response, PGE2 and VEGF serum levels obtained total tumor response (P = 0.048). Conclusion. Nutritional supplementation enriched PUFA (ratio of n-6: n-3 PUFA = 1.27 : 1) in advanced cervical cancer receiving radiotherapy gives better total tumor response.]"

"Penelitian ini membahas mengenai tingkat keberhasilan verifikasi kasus kanker serviks dengan kanker nasofaring. Dalam penelitian ini telah dievaluasi data film verifikasi penyinaran pasien radioterapi untuk jenis kanker serviks dan nasofaring. Jumlah pasien untuk jenis kanker serviks berjumlah 45 pasien dan untuk jenis kanker nasofaring 45 pasien. Peneliti tidak melakukan verifikasi secara langsung dan tidak berhubungan dengan pasien, Data diperoleh dari status pasien yang tersedia di Rumah Sakit Cipto Mangunkusumo . Hasil penelitian ini menunjukkan bahwa tingkat keberhasilan verifikasi kasus kanker nasofaring lebih tinggi dibandingkan dengan kasus kanker serviks.

---

My research study is focused on evaluating the verification success rates of cervical cancer and nasopharyngeal cancer survivors. 45 patients underwent radiotherapy procedures to identify specific types of the two mentioned cancers followed by data recording, for a total of 90 patients. The experimenter conducted no direct verification and had no direct contact with the patients since the data samples were obtained from Cipto Mangunkusumo Hospital. Research findings proved that the success rates of nasopharyngeal cancer verification were higher than the cervical cancer verification."

"ABSTRAKGangguan tidur mempengaruhi kualitas hidup anak yang mendapatkan kemoterapi. Penelitian bertujuan untuk mengidentifikasi pengaruh relaksasi otot progresif terhadap kualitas tidur dan efek samping kemoterapi pada anak dengan kanker. Desain penelitian randomized clinical trial dengan metode single blind, 30 anak secara random dialokasikan pada kelompok kontrol dan kelompok intervensi. Kelompok intervensi mendapat relaksasi otot progresif 2x sehari, pagi dan malam hari, 15 menit setiap sesi selama 7 hari. Kelompok kontrol mendapat tindakan keperawatan rutin. Hasil penelitian menyimpulkan tidak ada perbedaan yang bermakna pada kedua kelompok terhadap fatigue, nyeri, dan mual muntah, namun bermakna pada kualitas tidur dimana terdapat penurunan skor kualitas tidur. Terapi relaksasi terutama relaksasi otot progresif dapat menjadi salah satu tindakan keperawatan untuk meningkatkan kualitas tidur dan mengurangi efek samping kemoterapi pada anak dengan kanker.

---

ABSTRACTSleep disturbances affects quality of life in children receiving chemotherapy. The aim of this study to identify the effect of progressive muscle relaxation for the sleep quality and side effects of chemotherapy in children with cancer. In this study randomized clinical trial with single blind method applied, 30 children were allocated randomly to the control group and intervention group. The intervention group received progressive muscle relaxation twice a day, in the morning and evening, 15 minutes each session for 7 days. Control group received routine nursing care. The study concluded there was no significant difference in the two groups on fatigue, pain, and nausea, vomiting, however progressive muscle relaxation significant on the quality of sleep in which there is a decrease in sleep quality scores. Relaxation therapy particularly progressive muscle relaxation may be one of the nursing care to improve sleep quality and reduce the side effects of chemotherapy in children with cancer. "

"Kanker merupakan penyakit tidak menular yang dikenali dengan adanya sel abnormal yang tumbuh cepat tak terkendali serta dapat menyebar ke bagian tubuh lain. Kanker menjadi penyebab utama kematian di dunia. Di Indonesia sendiri kejadian kanker cukup tinggi, yaitu sebanyak 136,2 juta kasus dari 100 ribu penduduk. Banyak upaya pengobatan kanker, diantaranya kemoterapi menggunakan sitostatika. Namun, agen sitostatika ini dapat mengakibatkan banyak efek samping karena dapat berefek pada sel normal yang sehat. Banyak pasien mengalami efek samping serius dan kegagalan pengobatan hingga kematian akibat kemoterapi. Tujuan penelitian ini adalah untuk memonitoring efek samping obat (ESO) dan mengetahui faktor-faktor yang memengaruhinya. Digunakan desain studi cross-sectional dan pengumpulan data secara retrospektif dari rekam medis pasien kanker yang menjalani kemoterapi di RSUI periode Januari 2022—April 2024. Dilakukan analisis indikasi ESO dari kejadian tidak diinginkan (KTD) yang dialami oleh pasien. Terdapat 29 jenis ESO yang dialami oleh pasien, didominasi oleh ESO hematologi berupa anemia, leukopenia, dan trombositopenia serta ESO pada gastrointestinal berupa mual, muntah, dan anoreksia. Dari 20 pasien yang diambil dengan total sampling, sebagian besar menderita mieloma multipel, berjenis kelamin perempuan, berusia ≥60 tahun, memiliki komorbid, menggunakan 1—2 sitostatika, dan memiliki fungsi ginjal abnormal. Kemudian ESO pada pasien dianalisis probabilitasnya menggunakan algoritma Naranjo dan keparahannya menggunakan formulir CTCAE. Hasil analisis untuk tiap karakteristik pasien meliputi jenis kelamin, usia, komorbiditas, jumlah sitostatika, dan fungsi ginjal dengan keparahan dan probabilitas ESO menggunakan uji Chi-Square/Fisher’s Exact, semuanya menunjukkan nilai p >0,05, sehingga disimpulkan bahwa tidak ada hubungan antara karakteristik tersebut dengan keparahan dan probabilitas ESO.

---

Cancer is a non-communicable disease recognized by the presence of abnormal cells that grow uncontrollably and can spread to other parts of the body. Cancer is the leading cause of death in the world. In Indonesia, the incidence of cancer is quite high, which is 136,2 million cases out of 100 thousand population. There are many cancer treatment, including chemotherapy using cytostatics. However, these cytostatic agents can cause many side effects because they can affect normal cells. Many patients experience serious side effects and treatment failure until death due to chemotherapy. This study aimed to monitor adverse drug reactions (ADRs) and determine the factors that influence them. A cross sectional study design was used and data were collected retrospectively from the medical records of cancer patients undergoing chemotherapy at RSUI from January 2022—April 2024. ADRs indications were analyzed from adverse events (AEs) experienced by patients. There were 29 types of ADRs experienced by patients, dominated by hematological ADRs (anemia, leukopenia, thrombocytopenia) and gastrointestinal ADRs (nausea, vomiting, anorexia). 20 patients taken by total sampling, most had multiple myeloma, female, aged ≥60 years, had comorbidities, used 1—2 cytostatics, and had abnormal renal function. Then the ADRs in patients were analyzed for probability using the Naranjo algorithm and severity using the CTCAE form. The results of the analysis for each patient characteristic including gender, age, comorbidities, number of cytostatics, and renal function with the severity and probability of ADRs using the Chi Square/Fisher's Exact test, all showed p >0.05, so it was concluded that there was no association between these characteristics with the severity and probability of ADRs."